THE US Food and Drug Administration (FDA) has approved Eucrisa (crisaborole) ointment to treat mild to moderate eczema (atopic dermatitis) in patients two years of age and older.
The PDE-4 inhibitor is not yet approved for marketing in Australia.
The above article was sent to subscribers in Pharmacy Daily's issue from 16 Dec 16
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 16 Dec 16